Errata (DOI:10.1016/j.ijrobp.2005.11.042);Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 5, 2006, Pages 1513-1518

  Andratschke, Nicolaus ^a   Schnaitera, Andrea ^a   Weber, Wolfgang A ^b   Caia, Lu ^a   Schill, Sabine ^a   Wiedenmann, Nicole ^c   Schwaiger, Markus ^a   Molls, Michael ^a   Nieder, Carsten ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Erythropoietin; Growth factors; Kidney; Radiation nephropathy; Radiation tolerance; Radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; GROWTH KINETICS; PATIENT TREATMENT; TISSUE;

ERYTHROPOIETIN; GROWTH FACTORS; KIDNEY; RADIATION NEPHROPATHY; RADIATION TOLERANCE;

RADIOTHERAPY;

ERYTHROPOIETIN; SUCCIMER TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; IRRADIATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; TISSUE INJURY;

EID: 33645355646     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.04.003     Document Type: Erratum

References (37)

1. W. Dorr, K. Spekl, C.L. Farrell Amelioration of acute oral mucositis by keratinocyte growth factor Fractionated irradiation Int J Radiat Oncol Biol Phys 54 2002 245 251
2. N.H. Terry, J. Brinkley, A.J. Doig Cellular kinetics of murine lung Model system to determine basis for radioprotection with keratinocyte growth factor Int J Radiat Oncol Biol Phys 58 2004 435 444
3. N. Andratschke, C. Nieder, R.E. Price Modulation of rodent spinal cord radiation tolerance by administration of platelet-derived growth factor Int J Radiat Oncol Biol Phys 60 2004 1257 1263
4. C. Nieder, R.E. Price, B. Rivera Experimental data for insulin-like growth factor-1 and basic fibroblast growth factor in prevention of radiation myelopathy (German) Strahlenther Onkol 178 2002 147 152
5. C. Nieder, N. Andratschke, R.E. Price Evaluation of insulin-like growth factor-1 for prevention of radiation-induced myelopathy Growth Factors 23 2005 15 18
6. S. Schultze-Mosgau, F. Wehrhan, F. Rodel Improved free vascular graft survival in an irradiated surgical site following topical administration of rVEGF Int J Radiat Oncol Biol Phys 57 2003 803 812
7. E.P. Cohen, M.E. Robbins Radiation nephropathy Semin Nephrol 23 2003 486 499
8. L.F. Fajardo, J.M. Brown, E. Glatstein Glomerular and juxta-glomerular lesions in radiation nephropathy Radiat Res 68 1976 177 183
9. J.J. Kruse, J.A. te Poele, A. Velds Identification of differentially expressed genes in mouse kidney after irradiation using microarray analysis Radiat Res 161 2004 28 38
10. A. Kuin, J.J. Kruse, F.A. Stewart Proteinuria and vascular changes after renal irradiation The role of reactive oxygen species (ROS) and vascular endothelial growth factor (VEGF) Radiat Res 159 2003 174 181
11. F.A. Stewart, Y. Oussoren, H. van Tinteren Loss of reirradiation tolerance in the kidney with increasing time after single or fractionated partial tolerance doses Int J Radiat Biol 66 1994 169 179
12. F.A. Stewart, J.A. Te Poele, A.F. van der Wal Radiation nephropathy-the link between functional damage and vascular mediated inflammatory and thrombotic changes Acta Oncol 40 2001 952 957
13. F. Farrell, A. Lee The erythropoietin receptor and its expression in tumor cells and other tissues Oncologist 9 Suppl. 5 2004 18 30
14. M.H. Echigoya, K. Obikane, T. Nakashima Glomerular localization of erythropoietin receptor mRNA and protein in neonatal and mature mouse kidney Nephron Exp Nephrol 100 2005 e21 e29
15. F.H. Bahlmann, R. Song, S.M. Boehm Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure Circulation 110 2004 1006 1012
16. S. Fishbane, L. Ragolia, T. Palaia Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells Kidney Int 65 2004 452 458
17. N.S. Patel, E.J. Sharples, S. Cuzzocrea Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo Kidney Int 66 2004 983 989
18. C.W. Yang, C. Li, J.Y. Jung Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney FASEB J 17 2003 1754 1755
19. S. Yalcin, S. Muftuoglu, E. Cetin Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin Med Oncol 20 2003 169 174
20. S.H. Lee, C. Li, S.W. Lim Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy Am J Nephrol 25 2005 64 76
21. J.E. Moulder, B.L. Fish, K.R. Regner Angiotensin II blockade reduces radiation-induced proliferation in experimental radiation nephropathy Radiat Res 157 2002 393 401
22. A. Taylor Jr, M. Kipper, K. Witztum Calculation of relative glomerular filtration rate and correlation with delayed technetium-99m DMSA imaging Clin Nucl Med 11 1986 28 35
23. J. Kawamura, H. Itoh, O. Yoshida In vivo estimation of renal volume using a rotating gamma camera for 99mTc-dimercaptosuccinic acid renal imaging Eur J Nucl Med 9 1984 168 172
24. E.P. Cohen, S. Hussain, J.E. Moulder Successful treatment of radiation nephropathy with angiotensin II blockade Int J Radiat Oncol Biol Phys 55 2003 190 193
25. J.E. Moulder Pharmacological intervention to prevent or ameliorate chronic radiation injuries Semin Radiat Oncol 13 2003 73 84
26. R. Barone, F. Borson-Chazot, R. Valkema Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC Relevance of kidney volume and dose rate in finding a dose-effect relationship J Nucl Med 46 Suppl. 1 2005 99S 106S
27. M. Auerbach, H. Ballard, J.R. Trout Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia A multicenter, open-label, randomized trial J Clin Oncol 22 2004 1301 1307
28. P.K. Chatterjee Pleiotropic renal actions of erythropoietin Lancet 365 2005 1890 1892
29. J.W. George, C.A. Bracco, K.M. Shannon Age-related differences in erythropoietic response to recombinant human erythropoietin Comparison in adult and infant rhesus monkeys Pediatr Res 1990 567 571
30. M. Henke, R. Laszig, C. Rube Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy Randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
31. D. Shasha, M.J. George, L.B. Harrison Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy Cancer 98 2003 1072 1079
32. L. Cai, W.A. Weber, S. Schill Evaluation of insulin-like growth factor-1 as a protective agent against radiation-induced kidney dysfunction in C3H mice A dose-finding study [Abstract] Int J Radiat Oncol Biol Phys 60 Suppl 2004 S364
33. T. Wun, L. Law, D. Harvey Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin Cancer 98 2003 1514 1520
34. A. Anagnostou, E.S. Lee, N. Kessimian Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells Proc Natl Acad Sci USA 87 1990 5978 5982
35. J. Muller-Ehmsen, A. Schmidt, B. Krausgrill Role of erythropoietin for angiogenesis and vasculogenesis - from embryonic development through adulthood Am J Physiol Heart Circ Physiol 290 2006 H331 H340
36. K. Nitta, K. Uchida, N. Kimata Endothelin-1 mediates erythropoietin- stimulated glomerular endothelial-cell dependent proliferation of mesangial cells Eur J Pharmacol 293 1995 491 494
37. R.S. Jaenke, M.E. Robbins, T. Bywaters Capillary endothelium. Target site of renal radiation injury Lab Invest 68 1993 396 405